2006 annual financial data
Nektar Therapeutics 2006 Operating cash flow margin
Direct answer
Operating cash flow margin was -42.58%.
Operating income was -159,230,000 USD and net income was -154,761,000 USD.
Operating cash flow was -92,715,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 217,718,000 USD
- Operating income
- -159,230,000 USD
- Net income
- -154,761,000 USD
- Operating cash flow
- -92,715,000 USD